by The growth of pharmaceutical companies has created a ripple effect far beyond healthcare. While health and medicine have experienced the most direct impact, pharmaceutical expansion is also influencing computers and technology, farming and fishing, and even sports and entertainment through drug development, digital health, animal medicines, performance science, and consumer wellness.
According to Towards Healthcare, the global pharmaceutical market was valued at USD 1.77 trillion in 2025 and is projected to reach USD 3.22 trillion by 2035, growing at a 6.15% CAGR. North America accounted for approximately 36% of the global market in 2025.
The impact can be understood across four major industries.
1. Health and Medicine – The Most Directly Affected
Health and medicine is clearly the industry most affected by pharmaceutical growth.
Pharmaceutical companies directly support drug discovery, clinical research, manufacturing, distribution, disease management, and patient treatment. The expansion of biologics, generics, specialty medicines, vaccines, cell and gene therapies, and personalized medicine is also changing how healthcare is delivered.
Towards Healthcare estimates that the U.S. pharmaceutical market was USD 520.4 billion in 2025 and is projected to reach approximately USD 965 billion by 2035, representing a 6.37% CAGR.
Government data also demonstrate the pharmaceutical sector’s broader economic importance. The U.S. Bureau of Economic Analysis (BEA) reported that pharmaceuticals were among the leading contributors to the increase in consumer spending on goods during 2024. Healthcare was also the leading contributor within consumer spending on services.
The U.S. Bureau of Labor Statistics estimates that pharmaceutical and medicine manufacturing employed about 350,500 people in 2024, with employment projected to reach 369,500 by 2034.
Why the impact is so strong:
- New therapies create demand for clinical services.
- Pharmaceutical R&D supports biotechnology and diagnostics.
- Drug manufacturing creates demand for CDMOs and suppliers.
- Hospitals and pharmacies become major distribution channels.
- Personalized medicine increases demand for diagnostics and genomic testing.
Towards Healthcare projects the global pharmaceutical manufacturing market to grow from USD 616.19 billion in 2025 to USD 1.095 trillion by 2035, at a 5.92% CAGR.
2. Computers and Technology – A Fast-Growing Connection
The pharmaceutical industry is increasingly becoming a technology-intensive industry.
Drug companies now rely on AI, machine learning, cloud computing, high-performance computing, digital twins, data analytics, automation, and laboratory software across discovery and manufacturing.
Government data support this connection. BEA’s R&D statistics specifically identify chemical manufacturing, including pharmaceuticals, and computer and electronic product manufacturing among R&D-intensive industries contributing to U.S. economic activity.
Pharmaceutical R&D investment is substantial. BEA data reported through the Federal Reserve’s FRED database show $150.3 billion in 2024 private fixed investment in R&D for pharmaceutical and medicine manufacturing.
Towards Healthcare also identifies AI and machine learning, 3D printing, and other advanced technologies as important trends influencing pharmaceutical manufacturing.
This creates opportunities for:
- AI drug discovery
- Computational chemistry
- Clinical-trial software
- Electronic health records
- Digital therapeutics
- Laboratory automation
- Pharmaceutical robotics
- Data analytics
- Connected medical devices
So, while technology is not as directly affected as healthcare, it is becoming one of the most strategically important industries supporting pharmaceutical growth.
3. Farming and Fishing A More Indirect but Important Impact
The connection between pharmaceuticals and agriculture is often overlooked.
Pharmaceutical companies and animal-health businesses support veterinary medicines, vaccines, antibiotics, antiparasitic treatments, and animal-health products used in livestock and food production.
The FDA reported that U.S. sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals increased 16% from 2023 to 2024. However, 2024 volume remained 27% below the 2015 peak.
The economic scale of animal agriculture is also substantial. USDA’s Economic Research Service reported that U.S. cash receipts from animals and animal products totaled $268.6 billion in 2024. Cattle and calves accounted for $112.1 billion, poultry and eggs for $70.2 billion, and dairy for $50.7 billion.
This illustrates why animal pharmaceuticals can have an important downstream impact on agriculture.
The relationship works both ways:
Pharmaceuticals → veterinary health → healthier livestock → productivity → agricultural output
However, compared with healthcare and technology, the pharmaceutical industry’s impact on farming and fishing is more specialized and indirect.
4. Sports and Entertainment – An Emerging Connection
Sports and entertainment have a less direct relationship with pharmaceutical companies, but the connection is becoming more visible.
Pharmaceutical innovation affects sports through:
- Injury treatment
- Pain management
- Rehabilitation
- Sports medicine
- Nutrition and metabolic health
- Clinical research
- Anti-doping regulations
- Recovery technologies
The broader healthcare ecosystem also intersects with sports through wearable devices, digital health platforms, remote monitoring, and personalized wellness.
However, it would be misleading to say that pharmaceutical growth has affected sports and entertainment to the same extent as healthcare or technology.
The relationship is primarily downstream and specialized, rather than fundamental to the industry’s core economics.
How Significant Is the Pharmaceutical Ecosystem?
The scale of pharmaceutical outsourcing also shows how many industries are now connected to drug development.
Towards Healthcare estimates that the global pharmaceutical CMO and CDMO market was USD 156.93 billion in 2025 and is projected to reach USD 340.37 billion by 2035, growing at an 8.05% CAGR.
Get a Preview of Our Industry Analysis: https://www.towardshealthcare.com/download-sample/6720
This creates demand across a large supplier ecosystem, including:
- Chemical manufacturers
- Biotechnology companies
- Packaging companies
- Logistics providers
- Laboratory services
- Contract research organizations
- IT companies
- Equipment manufacturers
- Cold-chain providers
- Regulatory consultants
In other words, pharmaceutical growth is increasingly becoming an ecosystem effect rather than a pharmaceutical-company-only effect.
Which Industry Is Most Affected?
A simple ranking would be:
| Industry | Impact from pharmaceutical growth | Main connection |
|---|---|---|
| Health & Medicine | Very High | Drugs, hospitals, diagnostics, clinical care |
| Computers & Technology | High | AI, R&D, data, automation, digital health |
| Farming & Fishing | Moderate | Veterinary drugs, vaccines, animal health |
| Sports & Entertainment | Lower / Indirect | Sports medicine, rehabilitation, wellness |
The Bigger Picture
The pharmaceutical industry is no longer operating in isolation. Its growth is increasingly connected with healthcare delivery, technology, manufacturing, agriculture, logistics, research, and consumer wellness.
Towards Healthcare’s forecast of the global pharmaceutical market reaching USD 3.22 trillion by 2035 highlights the scale of this transformation.
Government data reinforce the picture: pharmaceutical manufacturing supported 350,500 U.S. jobs in 2024, while pharmaceutical R&D investment reached approximately $150.3 billion that year.
Discover healthcare data, trends, and companies – all in one dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Pharma Geek is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium
